| S1P3受体拮抗剂TY-52156的合成工艺优化 |
| |
| 引用本文： | 樊玲玲,刘永淑,罗忠福,汤磊,李永. S1P3受体拮抗剂TY-52156的合成工艺优化[J]. 化学研究与应用, 2021, 33(4): 772-776 |
| |
| 作者姓名： | 樊玲玲 刘永淑 罗忠福 汤磊 李永 |
| |
| 作者单位： | 贵州医科大学药学院,贵州 贵阳 550025;贵州省化学合成药物研发利用工程技术研究中心,贵州 贵阳 550004 |
| |
| 基金项目： | 贵州省化学合成药物研发利用工程技术研究中心项目(黔科合[2016]平台人才5402)资助;贵州省普通高等学校药物化学工程研究中心项目(黔教合KY字[2014]219号)资助;贵州省科技支撑计划项目(黔科合支撑[2017]2835号)资助;贵州省科技计划项目(黔科合基础[2019]1269和[2020]1Y111号)资助;国家自然科学基金项目(32060627)资助。 |
| |
| 摘 要： | 以3,3-二甲基-2-丁酮、乙酸乙酯和对氯苯胺为起始原料,经Claisen缩合、氯代、重氮化、亲核取代等五步反应生成目标产物TY-52156,总收率为42.4％.目标化合物结构经1H-NMR、13C-NMR和HRMS确证.通过优化Claisen缩合(t-BuOK/MTBE)及亲核取代(AcONa/EtOH)两步的反应条...
|
| 关 键 词： | TY-52156 合成 工艺优化 |
Optimization of synthesis process of S1P3 receptor antagonist TY-52156 |
| |
| FAN Ling-ling,LIU Yong-shu,LUO Zhong-fu,TANG Lei,LI Yong. Optimization of synthesis process of S1P3 receptor antagonist TY-52156[J]. Chemical Research and Application, 2021, 33(4): 772-776 |
| |
| Authors: | FAN Ling-ling LIU Yong-shu LUO Zhong-fu TANG Lei LI Yong |
| |
| Affiliation: | (School of Pharmacy,Guizhou Medical University,Guiyang 550025,China;Guizhou Province Engineering Technology Research Center for Chemical Drug R&D,Guiyang 550004,China) |
| |
| Abstract: | Target product TY-52156 was obtained by classical Claisen condensation,chlorination,diazotization and nucleophilic substitution from starting materials 3,3-dimethyl-2-butanone,ethyl acetate and p-chloroaniline,and gave total yield in 42.4%.The structure of the target compound was confirmed by 1H-NMR,13C-NMR and HRMS.By optimizing the reaction conditions of Claisen condensation(t-BuOK/MTBE)and nucleophilic substitution(AcONa/EtOH),the total yield was increased 1.36 folds compared with the traditional process,which was more suitable for large-scale preparation of TY-52156. |
| |
| Keywords: | TY-52156 synthesis process optimization |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
